Clinical Trial Update: IPS Differentiated Cardiomyocytes Vein Transplantation for Chronic Heart Failure [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update for IPS differentiated cardiomyocytes vein transplantation in chronic heart failure across Phase 2 and Phase 3 stages.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• IPS differentiated cardiomyocytes vein transplantation

Snippet

Sponsor: Beijing University of Chinese Medicine | Conditions: Chronic Heart Failure | Phase 2, Phase 3 | Status: UNKNOWN